However, it seems likely that the AT1-R is involved in the pathophysiology of preeclampsia, since in both rat and mice it has been demonstrated that treatment with AT1-R blockers inhibited the development of clinical signs in models of preeclampsia [21,22]. The gene discussed is AGTR1; the disease is preeclampsia.